Research Peptide
Retatrutide
20mg
Triple Hormone Receptor Agonist
Retatrutide is a next-generation multi-receptor agonist that targets GLP-1, GIP, and Glucagon receptors. This innovative peptide is widely studied for its potential in metabolic regulation, weight management research, appetite control, and overall metabolic health investigations.
View Research Information Center
Mechanism of Action
How Retatrutide Works
Retatrutide is a tri-agonist that simultaneously activates GLP-1, GIP, and Glucagon receptors, working synergistically to influence multiple metabolic pathways.
Supports appetite regulation, insulin secretion, and metabolic balance.
Enhances insulin sensitivity and supports lipid metabolism research.
Promotes energy expenditure and supports metabolic adaptation.
Combined receptor activation may amplify overall metabolic responses.
Investigated for its role in reducing appetite and increasing satiety.
Studied for potential to increase thermogenesis and energy utilization.
Research Applications
Potential Benefits
Key Benefits in Research Studies
Studied for its role in body weight regulation.
Investigated for reducing hunger and food intake.
May support improvements in metabolic health indicators.
Supports glucose regulation in research models.
Studied for potential to boost energy metabolism.
Targets multiple pathways for holistic metabolic impact.
Technical Specifications
- Peptide
- Retatrutide
- Appearance
- White Lyophilized Powder
- Purity
- ≥99%
- Molecular Formula
- C187H291N45O59S
- Molecular Weight
- ~4,882.4 g/mol
- Storage After Reconstituted
- 2 °C TO 8°C
- Shelf Life
- 36 Months
- Grade
- Research Grade
- Application
- Laboratory Research
Quality Assurance
Manufactured under strict laboratory standards with purity verification and batch-controlled quality protocols.